MGTX and JNJ Related Headlines

Go Back

Feb 17, 2026 08:30AM Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

MGTX and JNJ Related Press Releases

Go Back

Feb 17, 2026 08:30AM Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

MGTX and JNJ Related SEC Filings

Go Back